Research interests

Translational research in esophagogastric carcinoma

I coordinate 5 clinical trials wherein I also perform translational research

ACTION: a phase Ib study on the addition of Nab-Paclitaxel to capecitabine and oxaliplatin in the first line treatment of metastatic esophagogastric carcinoma

PERFECT: PDL-1 targetin in resectable esophageal cancer: a phase II feasibility study of Atezolizumab and chemoradiation

REPEAT: Regorafenib in combination with paclitaxel in advanced esophagogastric carcinoma, a phase 1b study

SOX: feasibility study of adjuvant treatment with S-1 and oxaliplatin in patients with resectable esophageal cancer

TRAP: feasibility study of chemoradiation, Trastuzumab and Pertuzumab in resectable HER2+ esophageal carcinoma

specialisation

Medical Oncology: translational research in esophagogastric carcinoma

Research output

  1. Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer

    Research output: Contribution to journal › Article › Academic › peer-review

  2. A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: A single-arm phase ii feasibility trial (PERFECT)

    Research output: Contribution to journal › Article › Academic › peer-review

View all (12) »

ID: 3263719